ABEONA THERAPEUTICS INC. Stock Redeemed or Called During Period, Shares
ABEONA THERAPEUTICS INC. (ABEO) reported Stock Redeemed or Called During Period, Shares of 450.00 thousand shares for the 0-month period ending 2019-05-15, per its 10-K filed 2020-03-16.
Discontinued › Shareholders' Equity
us-gaap:StockRedeemedOrCalledDuringPeriodShares · last filed 2020-03-16
- 2019-05-15: Stock Redeemed or Called During Period, Shares 0 month 450.00K shares; Stock Redeemed or Called During Period, Shares 450.00K shares.
| Period end | Stock Redeemed or Called During Period, Shares 0 month | Stock Redeemed or Called During Period, Shares |
|---|---|---|
| 2019-05-15 | 450.00K shares 10-K · filed 2020-03-16 | 450.00K shares 10-Q · filed 2019-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |